177 related articles for article (PubMed ID: 27203738)
21. Basic principles and technologies for deciphering the genetic map of cancer.
Voidonikolas G; Kreml SS; Chen C; Fisher WE; Brunicardi FC; Gibbs RA; Gingras MC
World J Surg; 2009 Apr; 33(4):615-29. PubMed ID: 19115029
[TBL] [Abstract][Full Text] [Related]
22. High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival.
Storrs EP; Chati P; Usmani A; Sloan I; Krasnick BA; Babbra R; Harris PK; Sachs CM; Qaium F; Chatterjee D; Wetzel C; Goedegebuure SP; Hollander T; Anthony H; Ponce J; Khaliq AM; Badiyan S; Kim H; Denardo DG; Lang GD; Cosgrove ND; Kushnir VM; Early DS; Masood A; Lim KH; Hawkins WG; Ding L; Fields RC; Das KK; Chaudhuri AA
NPJ Precis Oncol; 2023 Oct; 7(1):105. PubMed ID: 37857854
[TBL] [Abstract][Full Text] [Related]
23. SMAD4 and KCNQ3 alterations are associated with lymph node metastases in oesophageal adenocarcinoma.
Foley K; Shorthouse D; Rahrmann E; Zhuang L; Devonshire G; Gilbertson RJ; ; Fitzgerald RC; Hall BA
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166867. PubMed ID: 37648039
[TBL] [Abstract][Full Text] [Related]
24. SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel.
Yamashita K; Sewastjanow-Silva M; Yoshimura K; Rogers JE; Rosa Vicentini E; Pool Pizzi M; Fan Y; Zou G; Li JJ; Blum Murphy M; Gan Q; Waters RE; Wang L; Ajani JA
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610978
[TBL] [Abstract][Full Text] [Related]
25. Somatic Mutational Analysis in Endoscopic Ultrasound-Guided Biopsy of Pancreatic Adenocarcinoma: Assessing Yield and Impact.
Dong S; Agarunov E; Fasullo M; Kim KY; Khanna L; Haber G; Janec E; Simeone D; Oberstein P; Gonda T
Am J Gastroenterol; 2024 Apr; ():. PubMed ID: 38546128
[TBL] [Abstract][Full Text] [Related]
26. Applied precision medicine in metastatic pancreatic ductal adenocarcinoma.
Taghizadeh H; Müllauer L; Mader RM; Schindl M; Prager GW
Ther Adv Med Oncol; 2020; 12():1758835920938611. PubMed ID: 32699558
[TBL] [Abstract][Full Text] [Related]
27. Molecular Targets and Therapies for Ampullary Cancer.
Patel MA; Kratz JD; Carlson AS; Ascencio YO; Kelley BS; LoConte NK
J Natl Compr Canc Netw; 2024 Jan; ():1-8. PubMed ID: 38181507
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic endoscopic ultrasonography: intratumoral injection for pancreatic adenocarcinoma.
Shirley LA; Aguilar LK; Aguilar-Cordova E; Bloomston M; Walker JP
Gastroenterol Res Pract; 2013; 2013():207129. PubMed ID: 23606830
[TBL] [Abstract][Full Text] [Related]
29. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.
Hadano N; Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Sueda T; Hiyama E
Br J Cancer; 2016 Jun; 115(1):59-65. PubMed ID: 27280632
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
[TBL] [Abstract][Full Text] [Related]
32. S768I Mutation in EGFR in Patients with Lung Cancer.
Leventakos K; Kipp BR; Rumilla KM; Winters JL; Yi ES; Mansfield AS
J Thorac Oncol; 2016 Oct; 11(10):1798-801. PubMed ID: 27211795
[TBL] [Abstract][Full Text] [Related]
33. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
Chabon JJ; Simmons AD; Lovejoy AF; Esfahani MS; Newman AM; Haringsma HJ; Kurtz DM; Stehr H; Scherer F; Karlovich CA; Harding TC; Durkin KA; Otterson GA; Purcell WT; Camidge DR; Goldman JW; Sequist LV; Piotrowska Z; Wakelee HA; Neal JW; Alizadeh AA; Diehn M
Nat Commun; 2016 Jun; 7():11815. PubMed ID: 27283993
[TBL] [Abstract][Full Text] [Related]
34. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.
Fox RG; Lytle NK; Jaquish DV; Park FD; Ito T; Bajaj J; Koechlein CS; Zimdahl B; Yano M; Kopp J; Kritzik M; Sicklick J; Sander M; Grandgenett PM; Hollingsworth MA; Shibata S; Pizzo D; Valasek M; Sasik R; Scadeng M; Okano H; Kim Y; MacLeod AR; Lowy AM; Reya T
Nature; 2016 Jun; 534(7607):407-411. PubMed ID: 27281208
[TBL] [Abstract][Full Text] [Related]
35. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Sohal DP; Mangu PB; Khorana AA; Shah MA; Philip PA; O'Reilly EM; Uronis HE; Ramanathan RK; Crane CH; Engebretson A; Ruggiero JT; Copur MS; Lau M; Urba S; Laheru D
J Clin Oncol; 2016 Aug; 34(23):2784-96. PubMed ID: 27247222
[TBL] [Abstract][Full Text] [Related]
36. Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells.
Zhang W; Bao L; Yang S; Qian Z; Dong M; Yin L; Zhao Q; Ge K; Deng Z; Zhang J; Qi F; An Z; Yu Y; Wang Q; Wu R; Fan F; Zhang L; Chen X; Na Y; Feng L; Liu L; Zhu Y; Qin T; Zhang S; Zhang Y; Zhang X; Wang J; Yi X; Zou L; Xin HW; Ditzel HJ; Gao H; Zhang K; Liu B; Cheng S
Oncotarget; 2016 Jun; 7(26):39768-39783. PubMed ID: 27206795
[TBL] [Abstract][Full Text] [Related]
37. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.
Dreyer SB; Jamieson NB; Evers L; Duthie F; Cooke S; Marshall J; Beraldi D; Knight S; Upstill-Goddard R; Dickson EJ; Carter CR; McKay CJ; Biankin AV; Chang DK
Chin Clin Oncol; 2019 Apr; 8(2):16. PubMed ID: 31070037
[TBL] [Abstract][Full Text] [Related]
39. Utility of Endoscopic Ultrasound-Guided Biopsy for Next-Generation Sequencing of Pancreatic Exocrine Malignancies.
Larson BK; Tuli R; Jamil LH; Lo SK; Deng N; Hendifar AE
Pancreas; 2018 Sep; 47(8):990-995. PubMed ID: 30028448
[TBL] [Abstract][Full Text] [Related]
40. New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer.
Imaoka H; Sasaki M; Hashimoto Y; Watanabe K; Ikeda M
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31387310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
